Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

Chronic Rejection Clinical Trial

Official title:
Pilot Study of Cycling Treatment of Deoxyspergualin in Biopsy-proven Chronic Rejection of Kidney Transplantation

Status Terminated

Clinical Trial Summary

The purpose of this study to examine the efficacy and safety of cycling treatment of deoxyspergualin in renal transplant patients with biopsy-proven chronic rejection.

Clinical Trial Description

The primary aim of this study is to investigate the efficacy of deoxyspergualin after the completion of 6 cycles treatment. The efficacy valuables are histological findings in renal grafts, renal function, proteinuria, graft survival, anti-HLA antibody. The safety data are also evaluated in the study. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Chronic Rejection

Clinical Trial Details

NCT number	NCT01052259
Study type	Interventional
Source	Nippon Kayaku Co.,Ltd.
Contact
Status	Terminated
Phase	N/A
Start date	June 2009
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00980967` - Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study	N/A
Completed	`NCT00283348` - New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy	N/A
Withdrawn	`NCT00261547` - Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients	Phase 1/Phase 2